Viewing Study NCT03348059


Ignite Creation Date: 2025-12-24 @ 2:33 PM
Ignite Modification Date: 2026-01-26 @ 5:42 AM
Study NCT ID: NCT03348059
Status: COMPLETED
Last Update Posted: 2017-11-20
First Post: 2017-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy
Sponsor: Hospices Civils de Lyon
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-10-01
Start Date Type: ACTUAL
Primary Completion Date: 2016-11-30
Primary Completion Date Type: ACTUAL
Completion Date: 2017-03-31
Completion Date Type: ACTUAL
First Submit Date: 2017-11-16
First Submit QC Date: None
Study First Post Date: 2017-11-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-11-16
Last Update Post Date: 2017-11-20
Last Update Post Date Type: ACTUAL